Literature DB >> 8852487

Cyclosporine nephrotoxicity and rejection crisis: diagnosis by urinary enzyme excretion.

B Bornstein1, J Arenas, J M Morales, M Praga, J L Rodicio, A Martinez, L Valdivieso.   

Abstract

The urinary enzymes alanine aminopeptidase (AAP; EC 3.4.11.2) and N-acetyl-B-D-glucosaminidase (NAG; EC 3.2.1.30) were measured daily in 35 renal transplant recipients during the early postoperative period. Each peak value of fractional excretion was corrected for its baseline value (CFE). CFE values above normal for both NAG and AAP were more frequently found in episodes of acute rejection than in cyclosporine acute nephrotoxicity episodes (76 vs. 0%; p < 0.001). Consequently, a rise in CFE levels for both NAG and AAP is strongly suggestive of acute rejection crisis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852487     DOI: 10.1159/000188903

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

Review 1.  Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.

Authors:  Uwe Christians; Jost Klawitter; Jelena Klawitter; Nina Brunner; Volker Schmitz
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-02       Impact factor: 4.481

2.  Enzymuria and low molecular weight protein excretion as the differentiating marker of complications in the early post kidney transplantation period.

Authors:  Jakub Kuźniar; Z Marchewka; R Krasnowski; M Boratyńska; A Długosz; M Klinger
Journal:  Int Urol Nephrol       Date:  2006-12-07       Impact factor: 2.370

3.  Enzymuria pattern in early post renal transplant period: Diagnostic usefulness in graft dysfunction.

Authors:  Banibrata Mukhopadhyay; Shashikant Chinchole; Valentine Lobo; Sishir Gang; Mohan Rajapurkar
Journal:  Indian J Clin Biochem       Date:  2004-07

4.  Oxidative stress and coenzyme Q10 supplementation in renal transplant recipients.

Authors:  A Długosz; J Kuźniar; E Sawicka; Z Marchewka; J Lembas-Bogaczyk; W Sajewicz; M Boratyńska
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.